Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study

Abstract

BackgroundAlthough evidence suggests frequent gastrointestinal (GI) involvement during coronavirus disease 2019 (COVID-19), endoscopic findings are scarcely reported.AimsWe aimed at registering endoscopic abnormalities and potentially associated risk factors among patients with COVID-19.MethodsAll consecutive patients with COVID-19 undergoing endoscopy in 16 institutions from high-prevalence regions were enrolled. Mann-Whitney U, χ2 or Fisher’s exact test were used to compare patients with major abnormalities to those with negative procedures, and multivariate logistic regression to identify independent predictors.ResultsBetween February and May 2020, during the first pandemic outbreak with severely restricted endoscopy activity, 114 endoscopies on 106 patients with COVID-19 were performed in 16 institutions (men=70.8%, median age=68 (58–74); 33% admitted in intensive care unit; 44.4% reporting GI symptoms). 66.7% endoscopies were urgent, mainly for overt GI bleeding. 52 (45.6%) patients had major abnormalities, whereas 13 bled from previous conditions. The most prevalent upper GI abnormalities were ulcers (25.3%), erosive/ulcerative gastro-duodenopathy (16.1%) and petechial/haemorrhagic gastropathy (9.2%). Among lower GI endoscopies, 33.3% showed an ischaemic-like colitis.Receiver operating curve analysis identified D-dimers >1850 ng/mL as predicting major abnormalities. Only D-dimers >1850 ng/mL (OR=12.12 (1.69–86.87)) and presence of GI symptoms (OR=6.17 (1.13–33.67)) were independently associated with major abnormalities at multivariate analysis.ConclusionIn this highly selected cohort of hospitalised patients with COVID-19 requiring endoscopy, almost half showed acute mucosal injuries and more than one-third of lower GI endoscopies had features of ischaemic colitis. Among the hospitalisation-related and patient-related variables evaluated in this study, D-dimers above 1850 ng/mL was the most useful at predicting major mucosal abnormalities at endoscopy.Trial registration numberClinicalTrial.gov (ID: NCT04318366).

SARS-CoV-2 infection and replication in human gastric organoids

“…Understanding the pathogenesis and the mechanisms for transmission is of utmost importance. A growing body of literature suggests that replication at the level of the gastrointestinal (GI) tract not only occurs in a large proportion of cases 2,3 , but it also extends the overall duration of shedding, after viral clearance from the respiratory tract has occurred 4 . Moreover, SARS-CoV-2 has been detected in adult stool samples 5 and in air samples of patients' toilet areas 6 .…”

Deciphering the role of the Pancreatic Secretome in Covid-19 associated Multi-Organ Dysfunctions

“…Recent reports have indicated the damage in the gastrointestinal mucosal barrier in COVID-19 patients (Massironi et al, 2020;Sharma and Riva, 2020;Vanella et al, 2021). The damage in the mucosal barrier may cause the digestive enzymes of the exocrine pancreas to enter into the systemic circulation (Altshuler et al, 2016).…”

Review of COVID-19, part 1: Abdominal manifestations in adults and multisystem inflammatory syndrome in children

“…A multicenter international study of 114 endoscopies performed on COVID-19 patients for acute GI bleeds, found that 25% of bleeds were caused by ulcers, 16% by erosive/ulcerative gastro-duodenopathy and 9% by petechial or hemorrhagic gastropathy (85). Utilizing multivariate regression analysis, the authors found that ICU admission, pre-existing frailty, and extended hospitalization had no impact on the risk of a positive endoscopy finding (85).…”